PP813 - Mapping the Landscape: Audiologists’ Perspectives on the Cochlear Implant Device Market

Abstract: This study seeks to fill a gap in the existing literature and explore audiologists’ perceptions on the current cochlear implant market. Specifically, this study will address associations audiologists hold between key issues such as device reliability, ease of use (of external components as well as programming software), and technology (within the sound processor and implant) across the three FDA-approved device manufacturers in the United States. This study will explore trends based on location, sex, and years of experience.

Summary: Cochlear implants (CIs) represent a well-established intervention for children and adults with significant hearing loss who receive limited benefit from conventional amplification. In the United States, three manufacturers currently hold FDA approval, offering patients and providers multiple device options. Selection, however, is not always a straightforward process. For some candidates, device choice may be restricted due to medical or surgical considerations or based on the clinic’s available contracts and the surgeon’s device preference. In many cases, though, patients and their families are presented with two or even all three options. The process of evaluating device features is often described as difficult, with recipients and parents reporting feelings of being underprepared despite exposure to extensive information from manufacturer promotional materials, audiologist and surgeon consultations, peer experiences, and online and social media resources. Prior studies indicate that audiologists are frequently regarded as the most trusted source of information guiding device selection; however, these professionals often strive to maintain neutrality in their counseling, even though their opinions, when expressed, are highly influential. This dynamic highlights a gap in the literature regarding how audiologists themselves perceive the current CI market and the factors they consider most critical when comparing devices.
The present study seeks to explore audiologists’ perceptions of the three FDA-approved cochlear implant manufacturers in the United States. Areas of interest include device reliability, ease of use of external components, usability of programming software, and technological advancements embedded within both internal and external components. Demographic and professional variables will be considered to examine whether audiologists’ perceptions vary according to location, sex, and years of clinical experience. Data will be collected and analyzed to identify patterns of association between audiologist characteristics and the value they place on specific device attributes.
Anticipated findings will address how audiologists conceptualize differences among manufacturers with respect to reliability, usability, and technological innovation. Results will also identify whether provider demographics influence perceptions; for example, if years of experience correlate with stronger preferences for programming features, or if practice setting and geographic region influence emphasis on device reliability or patient usability. Such insights will highlight the areas where audiologists converge in their perceptions and where variability exists, thereby clarifying how professional experience shapes comparative evaluation of devices.
By systematically investigating audiologists’ perspectives on cochlear implant manufacturers, this study aims to provide an important addition to the existing literature. Understanding these professional perceptions is essential because they not only inform clinical practice but also indirectly shape patient and family decision-making in device selection. Identifying consistencies and differences in audiologists’ views may also guide the development of more effective counseling strategies, promote transparency in patient education, and ultimately contribute to improved satisfaction and outcomes for CI recipients.